Detalles de la búsqueda
1.
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Blood
; 141(17): 2047-2061, 2023 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36724453
2.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol
; 102(10): 2741-2752, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592092
3.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695874
4.
STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2.
Future Oncol
; 19(9): 631-642, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37083373
5.
Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
Br J Haematol
; 198(1): 114-130, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362549
6.
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Ann Hematol
; 100(6): 1463-1471, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903952
7.
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.
Blood
; 132(12): 1225-1240, 2018 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29930011
8.
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Hematol Oncol
; 38(3): 244-256, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067259
9.
[Myelodysplastic syndromes]. / Myelodysplastische Syndrome.
Internist (Berl)
; 61(2): 175-184, 2020 Feb.
Artículo
en Alemán
| MEDLINE | ID: mdl-31925478
10.
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Ann Hematol
; 98(4): 897-907, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610279
11.
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
Genes Chromosomes Cancer
; 57(11): 547-556, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30248204
12.
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER).
Haematologica
; 108(8): 2244-2248, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601981
13.
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA.
J Med Genet
; 54(9): 640-650, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600436
14.
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.
Lancet Oncol
; 18(10): 1338-1347, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870615
15.
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Ann Hematol
; 96(6): 887-894, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28374162
16.
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
Cancer
; 122(12): 1871-9, 2016 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26990290
17.
Causes of death in 2877 patients with myelodysplastic syndromes.
Ann Hematol
; 95(6): 937-44, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27025507
18.
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Ann Hematol
; 95(2): 191-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596971
19.
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
Genes Chromosomes Cancer
; 54(12): 809-17, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26355708
20.
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]. / Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 59(4): 444-53, 2016 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-26979719